For the year ending 2025-12-31, AGL had -$20,147K decrease in cash & cash equivalents over the period. -$119,005K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -391,347 |
| Depreciation and amortization | 28,594 |
| Stock-based compensation expense | 49,119 |
| Impairments | 36,085 |
| Loss (income) from equity method investments | -1,835 |
| Distributions of earnings from equity method investments | 0 |
| Gain (loss) and adjustments on sales of assets, net | 14,000 |
| Other, net | 5,518 |
| Receivables, net | -344,585 |
| Prepaid expense and other current assets | 65,439 |
| Other assets | 133 |
| Medical claims and related payables | 1,894 |
| Accounts payable and accrued expenses | -85,585 |
| Other liabilities | -2,065 |
| Net cash provided by (used in) operating activities | -105,763 |
| Purchase of property and equipment | 13,242 |
| Purchase of intangible assets | 29,866 |
| Investments in loans receivable and other | 2,000 |
| Investments in marketable securities | 60,154 |
| Proceeds from maturities of marketable securities and other | 193,872 |
| Net cash paid in business combination | 0 |
| Proceeds from sale of business and property, net of cash divested | 0 |
| Net cash provided by (used in) investing activities | 88,610 |
| Proceeds from (payments for) equity issuances, net | -2,994 |
| Common stock repurchase | 0 |
| Repayments of long-term debt | 0 |
| Net cash provided by (used in) financing activities | -2,994 |
| Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents | -20,147 |
agilon health, inc. (AGL)
agilon health, inc. (AGL)